Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Strength
Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Pack Size
Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Form
Thalidomide Celgene-H-C-PSUSA-00002919-201810: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Source
European Medicines Agency
Safety Profile
Contraindications
Side Effects
Scan this QR code to access this page quickly on your mobile device.